Rhodojaponin VI indirectly targets Cav2.2 channels via N-ethylmaleimide-sensitive fusion protein to alleviate neuropathic pain

• Main Authors: Keliang Chen (Author), Tao Wang (Author), Yong Li (Author), Jun Wu (Author), Cheng-Xiao Zhao (Author), Sheng Liu (Author), Fengrun Sun (Author), Yehong Fang (Author), Jiahuan Hu (Author), Jinping Hu (Author), Chong-Jing Zhang (Author), Haibo Yu (Author), Chao Ma (Author), Shi-Shan Yu (Author)
• Format: Book
• Published: Elsevier, 2023-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Neuropathic pain is a chronic disease that severely afflicts the life and emotional status of patients, but currently available treatments are often ineffective. Novel therapeutic targets for the alleviation of neuropathic pain are urgently needed. Rhodojaponin VI, a grayanotoxin from Rhododendron m...